Article
Comparison of next-generation sequencing and mutation-specific platforms in clinical practice.
American journal of clinical pathology - 1 Apr 2015
Hinrichs John W J, van Blokland W T Marja, Moons Michiel J, Radersma Remco D, Radersma-van Loon Joyce H, de Voijs Carmen M A, Rappel Sophie B, Koudijs Marco J, Besselink Nicolle J M, Willems Stefan M, de Weger Roel A
Abstract excerpt
OBJECTIVES: To compare next-generation sequencing (NGS) platforms with mutation-specific analysis platforms in a clinical setting, in terms of sensitivity, mutation specificity, costs, capacity, and ease of use. METHODS: We analyzed 25 formalin-fixed, paraffin-embedded lung cancer samples of different size and tumor percentage for known KRAS and EGFR hotspot mutations with two dedicated genotyping platforms...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
